Healthcare & Medical Equipment Suppliers Sector Financials, Performance and Ratios
-
Sector Score
47.0 /100
Rank 13 out of 27 Sectors -
Advance/Decline
57/158
-
No. of Companies215
-
Avg. Market Cap10,888
-
Price to Earning Ratio34.92
-
Price to Earning Growth Ratio3.39
-
Price to Book Ratio13.23
-
Return on Equity21.62
-
Return on Capital Employed-
-
Return on Assets9.12
-
Dividend yield 1 year %0.24 %
-
Net Profit Growth Annual YoY %8.98 %
-
Net Profit Growth Qtr YoY %-28.13 %
-
Net Profit Growth Qtr QoQ %-10.85 %
Show more
*All values are market cap weighted averages.
*All Financial parameters are in Million USD.
Healthcare & Medical Equipment Suppliers Sector Market Breadth
- < -5%
- -2 to -5%
- 0 to -2%
- 0 to 2%
- 2 to 5%
- > 5%
Healthcare & Medical Equipment Suppliers Peer comparison
Compare all stocks in Healthcare & Medical Equipment Suppliers industry listed on stock exchanges
| Stock Name | 3M Price Chart | Market Cap | LTPLast Traded Price | Day High Low (%) | Week High Low (%) | Month High Low (%) | Qtr High Low(%) | 1 Year High low(%) | 3 Year High low(%) | 5 Year High low(%) | 10 Year High low(%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Agilent Tech |
|
38,286.5
|
135.1
|
L
 -2.6%
H
134.0
138.4
|
L
 -3.3%
H
134.0
141.2
|
L
 -2.4%
H
134.0
150.1
|
L
 -8.8%
H
134.0
160.3
|
L
 -10.8%
H
96.4
160.3
|
L
 -13.3%
H
96.4
160.3
|
L
 6.9%
H
96.4
179.6
|
L
 255.6%
H
34.2
179.6
|
| Amerisource Bergen Corp |
|
-
|
353.5
|
L
 0.3%
H
347.6
353.6
|
L
 -0.4%
H
342.7
359.0
|
L
 4.0%
H
329.1
359.0
|
L
 6.2%
H
329.1
377.5
|
L
 21.8%
H
273.4
377.5
|
L
 119.0%
H
147.5
377.5
|
L
 228.0%
H
100.7
377.5
|
L
 288.4%
H
68.4
377.5
|
| Abbott |
|
186,789.6
|
107.4
|
L
 -1.1%
H
106.1
110.1
|
L
 -11.8%
H
105.8
122.5
|
L
 -13.9%
H
105.8
129.5
|
L
 -15.3%
H
105.8
132.0
|
L
 -14.1%
H
105.8
141.2
|
L
 -4.5%
H
89.7
141.2
|
L
 -4.8%
H
89.7
142.6
|
L
 168.3%
H
36
142.6
|
| Alcon Inc - Registered Shares |
|
39,438.4
|
80.3
|
L
 -0.9%
H
79.6
80.5
|
L
 1.6%
H
78.3
82.1
|
L
 0.2%
H
76.7
82.5
|
L
 5.5%
H
72.1
82.5
|
L
 -9.8%
H
71.6
99.2
|
L
 8.8%
H
63.8
101.1
|
L
 8.5%
H
55.2
101.1
|
L
H
39.4
101.1
|
| Artivion Inc |
|
2,038.1
|
43.0
|
L
 -2.1%
H
42.5
43.9
|
L
 -0.9%
H
42.5
45.4
|
L
 -8.3%
H
41.8
47.1
|
L
 -0.9%
H
41.8
48.3
|
L
 40.3%
H
22.0
48.3
|
L
 236.1%
H
11.4
48.3
|
L
 70.4%
H
9.6
48.3
|
L
 341.7%
H
8.9
48.3
|
| Avanos Medical Inc |
|
607.6
|
13.1
|
L
 -0.1%
H
12.9
13.2
|
L
 6.1%
H
12.1
13.3
|
L
 14.8%
H
11.1
13.3
|
L
 11.0%
H
10.6
13.3
|
L
 -17.2%
H
9.3
17.7
|
L
 -56.0%
H
9.3
32.0
|
L
 -72.5%
H
9.3
53.6
|
L
 -47.5%
H
9.3
73.0
|
| Baxter International |
|
10,198.9
|
19.8
|
L
 -1.2%
H
19.4
20.0
|
L
 -1.3%
H
19.4
20.4
|
L
 3.8%
H
19.0
21.3
|
L
 -13.8%
H
17.4
23.3
|
L
 -38.9%
H
17.4
37.7
|
L
 -55.8%
H
17.4
50.2
|
L
 -75.0%
H
17.4
89.7
|
L
 -45.0%
H
17.4
95.2
|
| Becton, Dickinson and Co. |
|
57,491.6
|
201.8
|
L
 -2.1%
H
195.6
205.5
|
L
 -2.6%
H
195.6
207.6
|
L
 2.9%
H
192.5
209.3
|
L
 8.6%
H
162.3
209.3
|
L
 -17.1%
H
162.3
251.9
|
L
 -17.9%
H
162.3
287.3
|
L
 -20.1%
H
162.3
287.3
|
L
 42.9%
H
126.3
287.3
|
| Butterfly Network Inc (Class A) |
|
1,139.2
|
4.5
|
L
 -4.0%
H
4.5
4.9
|
L
 8.4%
H
4.0
4.9
|
L
 14.2%
H
3.7
5.0
|
L
 102.2%
H
1.9
5.0
|
L
 15.6%
H
1.3
5.0
|
L
 59.4%
H
0.7
5.0
|
L
 -78.9%
H
0.7
29.1
|
L
H
0.7
29.1
|
| Bio-Rad Laboratories Inc (Class A) |
|
7,999.9
|
296.6
|
L
 -2.8%
H
293.9
308.6
|
L
 -5.4%
H
293.9
316.6
|
L
 -1.7%
H
293.9
328.6
|
L
 -12.7%
H
293.9
343.1
|
L
 -16.4%
H
211.4
373.7
|
L
 -35.1%
H
211.4
509.6
|
L
 -50.1%
H
211.4
832.7
|
L
 133.4%
H
122.7
832.7
|
| Bausch + Lomb Corp |
|
6,014.1
|
17.0
|
L
 -1.2%
H
16.7
17.1
|
L
 -1.1%
H
16.7
17.5
|
L
 -0.2%
H
16.2
17.9
|
L
 9.4%
H
14.4
17.9
|
L
 -1.2%
H
10.5
18.1
|
L
 -0.2%
H
10.5
22.0
|
L
H
10.5
22.0
|
L
H
10.5
22.0
|
| Boston Scientific |
|
137,194.2
|
92.5
|
L
 1.3%
H
90.9
92.6
|
L
 5.0%
H
87.0
93.1
|
L
 -3.8%
H
87.0
100.9
|
L
 -8.5%
H
87.0
105.7
|
L
 -9.3%
H
86.0
109.5
|
L
 101.8%
H
45.4
109.5
|
L
 149.8%
H
35.0
109.5
|
L
 418.3%
H
15.7
109.5
|
| Cardinal Health |
|
49,498.2
|
208.3
|
L
 0.7%
H
206.7
210.8
|
L
 -1.9%
H
206.3
213.4
|
L
 0.4%
H
199.9
215.5
|
L
 28.7%
H
161.4
215.5
|
L
 61.7%
H
120.7
215.5
|
L
 178.3%
H
68.5
215.5
|
L
 276.1%
H
45.9
215.5
|
L
 155.3%
H
39.1
215.5
|
| Conmed Corp |
|
1,289.2
|
41.6
|
L
 -1.3%
H
41.2
42
|
L
 0.1%
H
40.7
42.7
|
L
 3.6%
H
39.6
45.7
|
L
 -12.8%
H
38.3
48.4
|
L
 -39.5%
H
38.3
74.7
|
L
 -57.4%
H
38.3
138.5
|
L
 -65.4%
H
38.3
159.1
|
L
 6.5%
H
35.5
159.1
|
| Cooper Companies |
|
15,931.1
|
81.3
|
L
 -1.8%
H
80.8
82.5
|
L
 -1.3%
H
80.2
83.8
|
L
 -1.6%
H
80.1
85.0
|
L
 10.6%
H
67.2
89.8
|
L
 -16.8%
H
61.8
100.2
|
L
 -5.2%
H
61.8
112.4
|
L
 -14.4%
H
61.1
115.9
|
L
 154.3%
H
31.0
115.9
|
| Danaher |
|
165,999.2
|
235.0
|
L
 -2.1%
H
233.6
240.8
|
L
 -0.4%
H
231.1
242.8
|
L
 1.7%
H
227.2
242.8
|
L
 5.4%
H
207.7
242.8
|
L
 -4.4%
H
171.0
258.2
|
L
 -13.5%
H
171.0
281.7
|
L
 -1.3%
H
171.0
334.0
|
L
 263.3%
H
61.6
334.0
|
| Edwards Lifesciences |
|
48,547.9
|
83.7
|
L
 -0.9%
H
83.4
85
|
L
 -0.8%
H
82.8
86.2
|
L
 -3.1%
H
81.3
87.4
|
L
 9.9%
H
75.5
87.9
|
L
 21.3%
H
65.9
87.9
|
L
 8.5%
H
58.9
96.1
|
L
 -2.2%
H
58.9
131.7
|
L
 218.3%
H
25.1
131.7
|
| Glaukos Corp |
|
6,891.0
|
120.0
|
L
 -4.7%
H
119.9
125.0
|
L
 -0.2%
H
118.3
130.2
|
L
 2.9%
H
94.0
130.2
|
L
 60.7%
H
73.2
130.2
|
L
 -25.1%
H
73.2
161.8
|
L
 149.1%
H
44.3
163.7
|
L
 37.6%
H
33.3
163.7
|
L
 634.3%
H
14.3
163.7
|
| Globus Medical Inc (Class A) |
|
12,382.8
|
92.5
|
L
 -2.2%
H
91.3
95
|
L
 -1.0%
H
91.1
95.2
|
L
 4.6%
H
85.7
101.4
|
L
 48.5%
H
59.5
101.4
|
L
 -0.3%
H
51.8
101.4
|
L
 24.8%
H
43.4
101.4
|
L
 41.6%
H
43.4
101.4
|
L
 265.4%
H
19.3
101.4
|
| Haemonetics Corp |
|
3,221.4
|
68.8
|
L
 -1.7%
H
68.5
70.6
|
L
 -4.6%
H
68.5
73
|
L
 -14.0%
H
68.5
86.1
|
L
 34.3%
H
49.0
87.3
|
L
 -2.8%
H
47.3
87.3
|
L
 -24.0%
H
47.3
98.0
|
L
 -41.1%
H
43.5
142.1
|
L
 128.1%
H
26.0
142.1
|
| Herbalife Nutrition Ltd |
|
1,719.1
|
16.6
|
L
 -1.8%
H
16.2
17.1
|
L
 -1.9%
H
16.2
17.7
|
L
 17.4%
H
12.6
17.7
|
L
 99.5%
H
7.6
17.7
|
L
 158.0%
H
5.0
17.7
|
L
 -2.5%
H
5.0
21.3
|
L
 -66.5%
H
5.0
59
|
L
 -28.0%
H
5.0
61.8
|
| Inspire Medical Systems Inc |
|
2,307.1
|
79.4
|
L
 -1.7%
H
77.8
81.4
|
L
 -13.9%
H
77.8
97.5
|
L
 -17.0%
H
77.8
102.6
|
L
 2.4%
H
71.5
147.0
|
L
 -57.9%
H
70.8
203.1
|
L
 -68.2%
H
70.8
330
|
L
 -64.0%
H
70.8
330
|
L
H
22.5
330
|
| Integer Holdings Corp |
|
3,021.4
|
86.2
|
L
 0.8%
H
83.9
86.4
|
L
 0.5%
H
83.9
87.7
|
L
 9.6%
H
76.2
87.7
|
L
 18.3%
H
62
87.7
|
L
 -39.5%
H
62
146.4
|
L
 17.7%
H
62
146.4
|
L
 9.1%
H
50.1
146.4
|
L
 135.0%
H
18.1
146.4
|
| McKesson |
|
101,238.2
|
820.2
|
L
 0.4%
H
810.7
822.4
|
L
 -2.4%
H
807
847.9
|
L
 -0.8%
H
794.6
847.9
|
L
 2.3%
H
790.0
895.6
|
L
 38.7%
H
570.5
895.6
|
L
 117.9%
H
331.8
895.6
|
L
 343.3%
H
169.3
895.6
|
L
 382.0%
H
106.1
895.6
|
| Medtronic |
|
129,329.6
|
100.9
|
L
 -0.5%
H
100.2
101.7
|
L
 4.3%
H
95.7
102.1
|
L
 4.5%
H
95.2
102.1
|
L
 7.7%
H
89.0
106.3
|
L
 11.9%
H
79.6
106.3
|
L
 24.9%
H
68.9
106.3
|
L
 -13.5%
H
68.9
135.9
|
L
 32.9%
H
68.9
135.9
|
| Mettler-Toledo International |
|
28,729.8
|
1,406.4
|
L
 -2.2%
H
1392.2
1433.8
|
L
 -3.7%
H
1390.0
1456.8
|
L
 -0.8%
H
1384.5
1514.4
|
L
 -2.0%
H
1359.6
1525.2
|
L
 5.7%
H
946.7
1525.2
|
L
 -8.4%
H
928.5
1616.0
|
L
 13.9%
H
928.5
1714.8
|
L
 344.7%
H
291.3
1714.8
|
| Envista Holdings Corp |
|
3,919.9
|
23.8
|
L
 -2.3%
H
23.8
24.7
|
L
 -5.6%
H
23.8
25.3
|
L
 8.4%
H
21.6
25.4
|
L
 17.1%
H
18.8
25.4
|
L
 11.1%
H
14.2
25.4
|
L
 -35.5%
H
14.2
43.3
|
L
 -34.8%
H
14.2
52.0
|
L
H
10.1
52.0
|
| Owens & Minor Inc |
|
163.2
|
2.1
|
L
H
2.0
2.2
|
L
 -16.3%
H
2.0
2.5
|
L
 -22.1%
H
1.8
2.9
|
L
 -61.7%
H
1.8
5.6
|
L
 -85.9%
H
1.8
15.5
|
L
 -89.2%
H
1.8
28.4
|
L
 -92.3%
H
1.8
49.2
|
L
 -93.8%
H
1.8
49.2
|
| Penumbra Inc |
|
14,093.7
|
359.3
|
L
 0.2%
H
358.2
360.5
|
L
 2.4%
H
350.0
362.4
|
L
 13.7%
H
290
362.4
|
L
 42.0%
H
221.3
362.4
|
L
 31.1%
H
221.3
362.4
|
L
 47.5%
H
148
362.4
|
L
 47.2%
H
114.9
362.4
|
L
 701.7%
H
40.2
362.4
|
| Koninklijke Philips N.V. (ADR) |
|
27,958.8
|
29.4
|
L
 -1.1%
H
29.1
29.4
|
L
 -0.6%
H
28.4
29.8
|
L
 9.0%
H
26.9
30.3
|
L
 2.0%
H
26.1
30.3
|
L
 9.4%
H
21.5
30.3
|
L
 73.9%
H
15.6
32.9
|
L
 -47.1%
H
11.8
61.2
|
L
 21.6%
H
11.8
61.2
|
| Qiagen NV |
|
11,457.7
|
55.6
|
L
 2.5%
H
53.4
55.7
|
L
 16.9%
H
46.1
57.8
|
L
 16.2%
H
46.1
57.8
|
L
 7.1%
H
45.1
57.8
|
L
 12.6%
H
39.6
57.8
|
L
 -0.5%
H
38.8
57.8
|
L
 -8.3%
H
38.8
65.9
|
L
 111.7%
H
23.1
65.9
|
| Vicarious Surgical Inc (Class A) |
|
17.9
|
2.5
|
L
 0.8%
H
2.5
2.8
|
L
 -5.3%
H
2.4
2.8
|
L
 28.1%
H
1.8
3.3
|
L
 -57.1%
H
1.8
6.1
|
L
 -82.6%
H
1.8
16.4
|
L
 -99.9%
H
1.8
3199.5
|
L
 -100.0%
H
1.8
14207.0
|
L
H
1.8
14207.0
|
| ResMed |
|
36,839.0
|
252.4
|
L
 -1.2%
H
250.2
255.6
|
L
 -2.0%
H
250.2
264.1
|
L
 3.3%
H
240
264.1
|
L
 -2.7%
H
237.6
264.1
|
L
 0.8%
H
199.9
293.8
|
L
 8.0%
H
132.2
293.8
|
L
 17.1%
H
132.2
301.3
|
L
 338.4%
H
55.1
301.3
|
| Steris PLC |
|
25,471.1
|
259.5
|
L
 -0.5%
H
255.7
261.7
|
L
 -3.4%
H
255.7
267.1
|
L
 1.5%
H
246.7
269.4
|
L
 7.8%
H
232.2
269.4
|
L
 19.6%
H
204.9
269.4
|
L
 26.7%
H
173.2
269.4
|
L
 37.5%
H
159.2
269.4
|
L
 273.1%
H
61.4
269.4
|
| Stevanato Grp Spa |
|
4,714.8
|
17.3
|
L
 -9.9%
H
16.3
19.4
|
L
 -12.6%
H
16.3
19.9
|
L
 -17.6%
H
16.3
22
|
L
 -33.9%
H
16.3
27
|
L
 -19.8%
H
16.3
28
|
L
 -15.0%
H
16.3
36.3
|
L
H
13.4
36.3
|
L
H
13.4
36.3
|
| Stryker |
|
135,775.7
|
355.0
|
L
 -1.0%
H
350.8
358.6
|
L
 -2.4%
H
350.8
365.3
|
L
 0.1%
H
344.6
370.9
|
L
 -7.0%
H
344.6
383.9
|
L
 -10.0%
H
329.2
406.2
|
L
 38.8%
H
249.0
406.2
|
L
 48.0%
H
188.8
406.2
|
L
 278.1%
H
93.4
406.2
|
| Smith & Nephew PLC (ADR) |
|
14,137.8
|
33.3
|
L
 0.7%
H
32.9
33.3
|
L
 1.9%
H
32.1
33.3
|
L
 1.4%
H
31.9
34.2
|
L
 -9.0%
H
31.8
37.1
|
L
 32.8%
H
23.9
38.8
|
L
 17.4%
H
21.5
38.8
|
L
 -26.5%
H
21.5
45.6
|
L
 1.4%
H
21.5
52.3
|
| Teleflex Incorporated |
|
4,569.7
|
103.4
|
L
 -1.6%
H
102.5
105.5
|
L
 0.4%
H
100.2
107.1
|
L
 -15.5%
H
100.2
127.5
|
L
 -21.6%
H
100.2
137.0
|
L
 -42.9%
H
100.2
185.9
|
L
 -56.1%
H
100.2
276.4
|
L
 -73.2%
H
100.2
449.4
|
L
 -23.9%
H
100.2
449.4
|
| Thermo Fisher |
|
235,185.7
|
626.0
|
L
 -2.1%
H
622.7
639.2
|
L
 1.2%
H
606
644.0
|
L
 8.1%
H
576.9
644.0
|
L
 9.3%
H
551.6
644.0
|
L
 8.9%
H
385.5
644.0
|
L
 7.8%
H
385.5
644.0
|
L
 21.6%
H
385.5
672.3
|
L
 362.6%
H
119.8
672.3
|
| Waters |
|
23,361.2
|
392.3
|
L
 -2.0%
H
386.1
401.1
|
L
 1.3%
H
376.5
401.1
|
L
 1.9%
H
373.5
408.7
|
L
 9.1%
H
340.1
414.2
|
L
 -4.6%
H
275.1
423.6
|
L
 17.4%
H
231.9
423.6
|
L
 43.4%
H
231.9
428.2
|
L
 208.4%
H
112
428.2
|
| West Pharma Services |
|
17,026.1
|
236.7
|
L
 -4.5%
H
232.1
246.1
|
L
 -8.9%
H
232.1
258.7
|
L
 -14.5%
H
232.1
291.4
|
L
 -20.4%
H
232.1
301
|
L
 -31.4%
H
187.4
348.9
|
L
 -8.4%
H
187.4
415.7
|
L
 -21.1%
H
187.4
475.4
|
L
 308.5%
H
53.9
475.4
|
| Zimmer Biomet Holdings |
|
17,162.5
|
86.6
|
L
 -1.1%
H
86.1
87.9
|
L
 -0.8%
H
85.8
89
|
L
 -4.0%
H
85.8
95.3
|
L
 -16.0%
H
85.3
103.7
|
L
 -21.9%
H
85.3
114.4
|
L
 -31.0%
H
85.3
149.3
|
L
 -42.8%
H
85.3
169.7
|
L
 -7.2%
H
70.0
169.7
|
| BioRad Laboratories Inc |
|
9,003.8
|
312.8
|
L
H
312.8
312.8
|
L
 0.7%
H
312.8
312.8
|
L
 0.7%
H
312.8
312.8
|
L
 -2.6%
H
303.2
315.1
|
L
 -12.4%
H
225.3
359.2
|
L
 -5.9%
H
225.3
373.4
|
L
 -5.9%
H
225.3
373.4
|
L
 -5.9%
H
225.3
373.4
|
| Haleon PLC (ADR) |
|
46,578.7
|
10.5
|
L
 1.3%
H
10.3
10.5
|
L
 6.4%
H
9.9
10.5
|
L
 3.6%
H
9.7
10.5
|
L
 13.1%
H
9.0
10.5
|
L
 11.4%
H
8.7
11.4
|
L
 33.1%
H
7.5
11.4
|
L
H
5.6
11.4
|
L
H
5.6
11.4
|
| Revvity |
|
13,234.3
|
116.7
|
L
 -0.9%
H
115.8
118
|
L
 3.8%
H
110.2
118.3
|
L
 20.6%
H
95.9
118.3
|
L
 18.0%
H
88.5
118.3
|
L
 -5.2%
H
81.4
128.3
|
L
 -13.4%
H
79.5
145.4
|
L
 -23.2%
H
79.5
203.2
|
L
 137.6%
H
39.5
203.2
|
| Aethlon Medical Inc |
|
3.2
|
3.3
|
L
 7.5%
H
3.0
3.3
|
L
 12.3%
H
2.6
3.3
|
L
 31.7%
H
2.2
3.3
|
L
 -39.2%
H
2.2
5.9
|
L
 -93.5%
H
2.2
64
|
L
 -99.1%
H
2.2
695.6
|
L
 -99.8%
H
2.2
9992
|
L
 -100.0%
H
2.2
109078.8
|
| Ainos Inc |
|
12.8
|
1.8
|
L
 -2.1%
H
1.8
1.9
|
L
 -3.2%
H
1.8
2.0
|
L
 -7.1%
H
1.6
2.0
|
L
 -50.1%
H
1.6
3.7
|
L
 -54%
H
1.6
4.5
|
L
 -90.6%
H
1.6
45.8
|
L
 -97.3%
H
1.6
1781.3
|
L
 384.2%
H
0.1
1781.3
|
| Airsculpt Tech Inc |
|
173.6
|
2.8
|
L
 -4.5%
H
2.7
3.0
|
L
 14.4%
H
2.3
3.1
|
L
 28.1%
H
1.8
3.1
|
L
 -75.6%
H
1.8
12
|
L
 -45.6%
H
1.5
12
|
L
 -49.9%
H
1.5
12
|
L
H
1.5
18.5
|
L
H
1.5
18.5
|
| Align Tech |
|
12,106.4
|
168.7
|
L
 -0.1%
H
167.6
169.9
|
L
 -1.6%
H
164.4
172.4
|
L
 6.9%
H
154.6
174.7
|
L
 24.8%
H
130.2
174.7
|
L
 -27.7%
H
122
234.2
|
L
 -33.2%
H
122
413.2
|
L
 -68.4%
H
122
737.5
|
L
 176.8%
H
57.5
737.5
|
| Angiodynamic Inc |
|
427.8
|
10.4
|
L
 -2.4%
H
10.4
10.7
|
L
 -0.7%
H
10.2
10.9
|
L
 -21.1%
H
9.7
13.4
|
L
 -15.9%
H
9.7
14.0
|
L
 -14.9%
H
8.3
14.0
|
L
 -23.6%
H
5.3
14.0
|
L
 -43.0%
H
5.3
32
|
L
 -8.9%
H
5.3
32
|
| Anika Therapeutics Inc |
|
134.3
|
9.3
|
L
 -0.9%
H
9.2
9.5
|
L
H
9.2
9.6
|
L
 -1.8%
H
9.2
9.9
|
L
 -7.0%
H
9.2
10.8
|
L
 -42.9%
H
7.9
18.4
|
L
 -69.5%
H
7.9
32.3
|
L
 -76.1%
H
7.9
48.4
|
L
 -74.6%
H
7.9
75.7
|
| Apyx Medical Corp |
|
162.9
|
4.0
|
L
 0.5%
H
3.8
4
|
L
 -0.5%
H
3.8
4.2
|
L
 10.3%
H
3.4
4.2
|
L
 23.7%
H
2.8
4.4
|
L
 166.4%
H
0.8
4.4
|
L
 53.9%
H
0.8
8.0
|
L
 -63.8%
H
0.8
17.5
|
L
 80.5%
H
0.8
17.5
|
| Accuray Inc |
|
92.9
|
0.8
|
L
 -1.2%
H
0.8
0.9
|
L
 -2.4%
H
0.8
0.9
|
L
 -4.7%
H
0.8
0.9
|
L
 -47.8%
H
0.8
1.6
|
L
 -64.0%
H
0.8
3.0
|
L
 -66.9%
H
0.8
4.3
|
L
 -84.0%
H
0.8
6.0
|
L
 -86.4%
H
0.8
6.4
|
| Alphatec Holdings Inc |
|
2,320.4
|
15.6
|
L
 -1.1%
H
15.6
16.2
|
L
 -12.0%
H
15.6
17.5
|
L
 -24.8%
H
15.4
23.3
|
L
 -3.0%
H
15.4
23.3
|
L
 41.9%
H
8.8
23.3
|
L
 20.4%
H
4.9
23.3
|
L
 5.5%
H
4.9
23.3
|
L
 346.3%
H
1.2
23.3
|
| Atricure Inc |
|
1,942.4
|
39.1
|
L
 -2.4%
H
39.0
40.9
|
L
 0.0%
H
37.3
40.9
|
L
 -3.7%
H
36.1
43.2
|
L
 4.1%
H
30.9
43.2
|
L
 -3.7%
H
28.3
43.2
|
L
 -7.6%
H
18.9
59.6
|
L
 -33.9%
H
18.9
89.2
|
L
 108.4%
H
13.4
89.2
|
| Axogen Inc |
|
1,514.2
|
32.8
|
L
 2.6%
H
31.6
33.0
|
L
 5.8%
H
30.5
33.6
|
L
 0.6%
H
30.0
34.7
|
L
 80.7%
H
17.1
34.7
|
L
 81.0%
H
9.2
34.7
|
L
 203.1%
H
3.5
34.7
|
L
 75%
H
3.5
34.7
|
L
 555.3%
H
3.5
56.9
|
| Bone Biologics Corp |
|
3.1
|
1.7
|
L
 -1.7%
H
1.7
1.8
|
L
 -2.8%
H
1.7
1.8
|
L
 -5.0%
H
1.4
1.9
|
L
 -22.8%
H
1.3
2.4
|
L
 -72.8%
H
1.3
7.7
|
L
 -99.6%
H
1.3
576.9
|
L
 -100.0%
H
1.3
21600
|
L
H
1.3
169920
|
| BioAffinity Tech Inc |
|
6.1
|
1.4
|
L
 -0.7%
H
1.3
1.4
|
L
 -1.5%
H
1.3
1.4
|
L
 9.8%
H
1.1
1.5
|
L
 -49.1%
H
1.1
2.7
|
L
 -93.7%
H
1.1
46.5
|
L
 -98.4%
H
1.1
110.1
|
L
H
1.1
466.5
|
L
H
1.1
466.5
|
| Bluejay Diagnostics Inc |
|
1.5
|
0.8
|
L
 -5.8%
H
0.8
1
|
L
 17.1%
H
0.7
1
|
L
 15.5%
H
0.6
1
|
L
 -64.5%
H
0.6
2.4
|
L
 -81.5%
H
0.6
10.2
|
L
 -98.8%
H
0.1
140.8
|
L
H
0.1
1000
|
L
H
0.1
1000
|
| Biolife Soln Inc |
|
1,197.4
|
24.9
|
L
 -4.3%
H
24.6
25.9
|
L
 1.8%
H
23.8
26.5
|
L
 -2.1%
H
23.3
26.7
|
L
 -13.6%
H
23.3
28.9
|
L
 -10.5%
H
19.1
29.6
|
L
 -0.5%
H
8.9
29.6
|
L
 -39.9%
H
8.9
60.7
|
L
 1149.7%
H
1.4
60.7
|
| Biomerica Inc |
|
7.8
|
2.6
|
L
H
2.5
2.6
|
L
H
2.4
2.7
|
L
 -3.0%
H
2.3
2.9
|
L
 -13.2%
H
2.1
3.1
|
L
 328.3%
H
0.4
4.9
|
L
 -8.2%
H
0.2
4.9
|
L
 -63.2%
H
0.2
8.2
|
L
 107.3%
H
0.2
23.4
|
| Bruker Corp |
|
7,647.2
|
50.3
|
L
 -3.4%
H
49.4
52.1
|
L
 4.0%
H
46.8
53.5
|
L
 4.6%
H
46.8
56.2
|
L
 29.1%
H
36.1
56.2
|
L
 -12.2%
H
28.5
59.4
|
L
 -29.3%
H
28.5
94.9
|
L
 -17.3%
H
28.5
94.9
|
L
 118.4%
H
19.6
94.9
|
| BioRestorative Therapies Inc |
|
10.1
|
1.1
|
L
 -1.7%
H
1.1
1.2
|
L
 -0.9%
H
1.1
1.2
|
L
 -4.2%
H
1
1.3
|
L
 -27.4%
H
1.0
1.7
|
L
 -50.9%
H
1.0
2.6
|
L
 -63.2%
H
1.0
7.1
|
L
 -97.0%
H
1.0
132
|
L
 -100.0%
H
0.4
20040
|
| Biosig Tech Inc |
|
226.8
|
3.3
|
L
 -6.1%
H
3.0
3.4
|
L
 -8.2%
H
3.0
3.6
|
L
 -3.0%
H
2.9
3.7
|
L
 -33.1%
H
2.9
5.3
|
L
 218.6%
H
0.4
14.1
|
L
 291.6%
H
0.1
14.1
|
L
 -32.2%
H
0.1
14.1
|
L
 -18.3%
H
0.1
14.1
|
| Bioventus Inc (Class A) |
|
537.2
|
8.0
|
L
 -1.6%
H
8.0
8.3
|
L
 1.1%
H
7.6
8.3
|
L
 8.7%
H
7.1
8.3
|
L
 15.6%
H
6.5
8.3
|
L
 -20.0%
H
5.8
11.3
|
L
 289.3%
H
0.8
14.4
|
L
H
0.8
19.9
|
L
H
0.8
19.9
|
| Brainsway Ltd (ADR) |
|
451.2
|
23.0
|
L
 -4.8%
H
22.9
24.7
|
L
 -0.6%
H
21.9
24.8
|
L
 19.4%
H
18.3
24.8
|
L
 37.0%
H
14.3
24.8
|
L
 115.5%
H
7.8
24.8
|
L
 1052%
H
1.4
24.8
|
L
 131.6%
H
1.4
24.8
|
L
H
1.4
24.8
|
| Cardio Diagnostics Holdings Inc |
|
3.5
|
1.9
|
L
 -2.0%
H
1.9
2.0
|
L
 7.2%
H
1.7
2.0
|
L
 -43.3%
H
1.6
3.5
|
L
 -52.1%
H
1.6
4.5
|
L
 -85.9%
H
1.6
20.6
|
L
 -94.6%
H
1.6
255
|
L
H
1.6
307.5
|
L
H
1.6
307.5
|
| Caredx Inc |
|
1,050.3
|
20.4
|
L
 -2.9%
H
20.1
21.1
|
L
 2.1%
H
19.5
21.5
|
L
 3.5%
H
16.9
21.5
|
L
 36.4%
H
14.2
21.5
|
L
 -8.6%
H
11.0
25.6
|
L
 34.7%
H
4.8
34.8
|
L
 -76.1%
H
4.8
96.9
|
L
 287.5%
H
0.8
99.8
|
| Celcuity Inc |
|
5,092.2
|
110.1
|
L
 -0.7%
H
103
112.2
|
L
 2.9%
H
103
112.7
|
L
 7.3%
H
98.5
116.4
|
L
 55.1%
H
71.1
116.4
|
L
 863.7%
H
7.6
116.4
|
L
 867.9%
H
7.6
116.4
|
L
 665.3%
H
4.8
116.4
|
L
H
4.0
116.4
|
| Creative Medical Tech Holdings Inc |
|
7.3
|
2.1
|
L
 -6.7%
H
2.1
2.3
|
L
 5%
H
1.9
2.3
|
L
 -5.4%
H
1.5
2.5
|
L
 -57.0%
H
1.5
6.3
|
L
 -13.6%
H
1.5
6.9
|
L
 -58.8%
H
1.5
14.2
|
L
 -98.1%
H
1.5
650
|
L
 -100.0%
H
1.5
525000
|
| Cerus Corp |
|
478.3
|
2.5
|
L
 -5.0%
H
2.5
2.6
|
L
 -4.2%
H
2.4
2.7
|
L
 20.9%
H
1.9
3.0
|
L
 62.8%
H
1.4
3.0
|
L
 26.4%
H
1.1
3.0
|
L
 -20.2%
H
1.1
3.5
|
L
 -65.7%
H
1.1
8.4
|
L
 -55.3%
H
1.1
8.9
|
| Check-Cap Ltd |
|
9.1
|
1.5
|
L
 -2.6%
H
1.5
1.6
|
L
 -13.4%
H
1.5
1.7
|
L
 -16.8%
H
1.5
1.8
|
L
 -8.0%
H
1.2
2.1
|
L
 14.6%
H
0.6
3.1
|
L
 -51.6%
H
0.6
5.9
|
L
 -95.6%
H
0.6
89.8
|
L
 -100.0%
H
0.6
173376
|
| CollPlant biotech Ltd - Ordinary Shares New |
|
24.3
|
1.9
|
L
 24.2%
H
1.5
2.0
|
L
 26.7%
H
1.4
2.0
|
L
 29.3%
H
1.3
2.0
|
L
 -16.7%
H
1.3
2.4
|
L
 -48.8%
H
1.3
5.0
|
L
 -80.9%
H
1.3
14.0
|
L
 -87.0%
H
1.3
24.3
|
L
 -92.1%
H
1.3
24.3
|
| ClearPoint Neuro Inc |
|
466.5
|
15.7
|
L
 10.3%
H
14.6
16.5
|
L
 7.0%
H
13.5
16.5
|
L
 8.2%
H
13.4
16.6
|
L
 -36.6%
H
12.3
27.3
|
L
 -12.2%
H
9.8
30.1
|
L
 72.5%
H
4.1
30.1
|
L
 -29.7%
H
4.1
31.3
|
L
 -0.7%
H
1.3
31.3
|
| Cardiff Oncology Inc |
|
195.3
|
2.9
|
L
 -2.4%
H
2.9
3.1
|
L
 0.7%
H
2.7
3.1
|
L
 -8.8%
H
2.6
3.3
|
L
 30.0%
H
1.9
3.3
|
L
 -15.0%
H
1.9
5.0
|
L
 68.6%
H
0.9
6.4
|
L
 -73.4%
H
0.9
15.0
|
L
 -99.2%
H
0.7
499.0
|
| Castle Biosciences Inc |
|
1,232.9
|
42.2
|
L
 0.2%
H
41.1
42.3
|
L
 5.6%
H
39.7
43.0
|
L
 5.4%
H
37.3
43.0
|
L
 72.3%
H
23.3
43.0
|
L
 59.8%
H
14.6
43.0
|
L
 59.1%
H
9.3
43.0
|
L
 -46.6%
H
9.3
107.7
|
L
H
9.3
107.7
|
| Cytek BioSciences Inc |
|
673.8
|
5.3
|
L
 -5.4%
H
5.3
5.6
|
L
 -2.4%
H
5.2
5.7
|
L
 3.9%
H
4.9
6.0
|
L
 23.7%
H
3.7
6.2
|
L
 -8.2%
H
2.4
6.2
|
L
 -53.1%
H
2.4
13.8
|
L
H
2.4
28.7
|
L
H
2.4
28.7
|
| Cytosorbents Corp |
|
42.7
|
0.7
|
L
H
0.7
0.7
|
L
 -2.9%
H
0.7
0.7
|
L
 -1.5%
H
0.6
0.7
|
L
 -20%
H
0.6
0.9
|
L
 -34.6%
H
0.6
1.6
|
L
 -70.8%
H
0.6
4.6
|
L
 -92.9%
H
0.6
11.7
|
L
 -83.4%
H
0.6
15.0
|
| Citius Pharma Inc |
|
17.6
|
0.9
|
L
H
0.8
0.9
|
L
 -1.2%
H
0.7
0.9
|
L
 6.3%
H
0.7
1.0
|
L
 -53.3%
H
0.6
1.8
|
L
 -74.2%
H
0.6
3.4
|
L
 -97.1%
H
0.1
42.8
|
L
 -97.3%
H
0.1
114
|
L
 -99.9%
H
0.1
937.5
|
| CVRx Inc |
|
191.6
|
7.3
|
L
 11.4%
H
6.5
7.8
|
L
 40.3%
H
5.1
7.8
|
L
 -4.8%
H
5.1
8.7
|
L
 -30.1%
H
5.1
11.3
|
L
 -58.9%
H
4.3
17.8
|
L
 -49.8%
H
4.3
33.1
|
L
H
4.3
33.1
|
L
H
4.3
33.1
|
| Delcath Systems Inc |
|
365.4
|
10.5
|
L
 -4.1%
H
10.5
11.0
|
L
 1.5%
H
10.1
11.2
|
L
 2.0%
H
9.7
11.2
|
L
 2.9%
H
8.1
11.2
|
L
 -34.2%
H
8.1
18.2
|
L
 173.5%
H
2.3
18.2
|
L
 -36.9%
H
2.3
25.2
|
L
 -100.0%
H
2.3
838880000
|
| Alpha Tau Medical Ltd |
|
596.0
|
7.0
|
L
 -2.5%
H
6.9
7.4
|
L
 -1.8%
H
6.2
7.4
|
L
 38.4%
H
4.8
7.9
|
L
 65.3%
H
3.4
7.9
|
L
 73.5%
H
2.3
7.9
|
L
 62.6%
H
1.8
7.9
|
L
H
1.8
20.7
|
L
H
1.8
20.7
|
| DexCom |
|
28,416.6
|
72.9
|
L
 -1.4%
H
71.7
73.5
|
L
 4.8%
H
68.5
76.0
|
L
 8.1%
H
65.2
76.0
|
L
 3.6%
H
54.1
76.0
|
L
 -17.9%
H
54.1
93.2
|
L
 -31.3%
H
54.1
142
|
L
 -21.3%
H
54.1
164.9
|
L
 293.8%
H
10.7
164.9
|
| Daxor Corp |
|
63.4
|
12.6
|
L
 -8.1%
H
11.9
12.6
|
L
 -8.1%
H
11.9
13.7
|
L
 -8.9%
H
11.9
14.8
|
L
 -8.6%
H
11.4
14.8
|
L
 53.7%
H
6.6
14.8
|
L
 46.4%
H
6.6
14.8
|
L
 -1.9%
H
6.6
17.6
|
L
 66.8%
H
3.4
24.1
|
| ElectroCore Inc |
|
59.7
|
7.5
|
L
 6.1%
H
6.8
7.6
|
L
 4.6%
H
6.4
8
|
L
 53.1%
H
4.4
8
|
L
 50%
H
4.4
8
|
L
 -56.1%
H
4.2
19.5
|
L
 24.5%
H
3.1
19.5
|
L
 -81.3%
H
2.9
54.5
|
L
H
2.9
303.8
|
| Ekso Bionics Holdings Inc |
|
31.0
|
8.7
|
L
 10.1%
H
7.9
8.9
|
L
 -1.7%
H
6.9
8.9
|
L
 59.2%
H
5.4
12.7
|
L
 71.1%
H
3.5
12.7
|
L
 -94.0%
H
2.7
151.0
|
L
 -97.9%
H
2.7
704.0
|
L
 -99.6%
H
2.7
3370.5
|
L
 -100.0%
H
2.7
24232.5
|
| Embecta Corp |
|
647.8
|
10.9
|
L
 -9.4%
H
10.9
12.1
|
L
 -11.7%
H
10.9
12.5
|
L
 -9.4%
H
10.9
13.0
|
L
 -23.7%
H
10.9
14.9
|
L
 -42.3%
H
9.2
19.7
|
L
 -53.8%
H
9.2
33.9
|
L
H
9.2
63
|
L
H
9.2
63
|
| Establishment Labs Holdings Inc |
|
1,915.5
|
65.9
|
L
 -2.3%
H
65.5
68.3
|
L
 -2.4%
H
63.3
69.6
|
L
 -12.9%
H
63.3
76.7
|
L
 34.3%
H
47
78.2
|
L
 100.4%
H
26.6
78.2
|
L
 -2.2%
H
17
79.9
|
L
 24.4%
H
17
93.8
|
L
H
7.6
93.8
|
| Exact Sciences Corp |
|
19,420.9
|
102.3
|
L
 -0.1%
H
102.1
102.5
|
L
 -0.2%
H
102
102.7
|
L
 0.7%
H
101.5
102.7
|
L
 58.2%
H
62.4
102.7
|
L
 82.7%
H
38.8
102.7
|
L
 56.6%
H
38.8
102.7
|
L
 -31.8%
H
29.3
159.5
|
L
 1505.3%
H
4.7
159.5
|
| EDAP TMS S.A. (ADR) |
|
140.2
|
3.8
|
L
 5.0%
H
3.6
3.9
|
L
 -7.6%
H
3.4
3.9
|
L
 26.3%
H
3.0
4.2
|
L
 57.6%
H
1.8
4.2
|
L
 72.8%
H
1.2
4.2
|
L
 -65.1%
H
1.2
12.7
|
L
 -53.3%
H
1.2
12.7
|
L
 -4.1%
H
1.2
12.7
|
| GlucoTrack Inc |
|
3.3
|
3.6
|
L
 0.8%
H
3.6
3.8
|
L
 -8.6%
H
3.3
4.2
|
L
 -19.4%
H
3.2
4.5
|
L
 -45.2%
H
3.2
7.5
|
L
 -96.9%
H
3.2
134.5
|
L
 -100.0%
H
3.2
22500
|
L
 -100.0%
H
3.2
46800
|
L
 -100.0%
H
3.2
468000
|
| GE HealthCare Tech |
|
36,337.0
|
79.8
|
L
 -2.6%
H
79.6
81.8
|
L
 -2.4%
H
78.3
83.2
|
L
 -4.3%
H
78.3
89.8
|
L
 2.1%
H
70.0
89.8
|
L
 -10.0%
H
57.7
94.8
|
L
 14.6%
H
57.7
94.8
|
L
H
53
94.8
|
L
H
53
94.8
|
| Harvard Bioscience Inc |
|
26.3
|
0.6
|
L
 -4.8%
H
0.6
0.6
|
L
H
0.6
0.6
|
L
 -18.1%
H
0.6
0.7
|
L
 43.9%
H
0.4
0.9
|
L
 -66.1%
H
0.3
1.8
|
L
 -79.2%
H
0.3
6.3
|
L
 -86.6%
H
0.3
8.8
|
L
 -79.7%
H
0.3
8.8
|
| Hologic |
|
16,754.5
|
75.1
|
L
 -0.1%
H
75
75.2
|
L
 0.1%
H
74.9
75.3
|
L
 0.7%
H
74.4
75.3
|
L
 1.4%
H
73.9
75.3
|
L
 5.7%
H
51.9
75.3
|
L
 -8.0%
H
51.9
87.9
|
L
 -0.9%
H
51.9
87.9
|
L
 113.1%
H
26.5
87.9
|
| Heart Test Laboratories Inc |
|
11.0
|
3.5
|
L
H
3.5
3.6
|
L
 7.8%
H
3.1
3.7
|
L
 33.7%
H
2.6
3.7
|
L
 4.9%
H
2.0
3.7
|
L
 2.7%
H
2.0
6.5
|
L
 -95.6%
H
2.0
395
|
L
H
2.0
600
|
L
H
2.0
600
|
| Helius Medical Tech Inc (Class A) |
|
140.0
|
3.4
|
L
 5.6%
H
3.1
3.7
|
L
 2.7%
H
2.8
3.7
|
L
 19.8%
H
2.6
3.7
|
L
 -49.4%
H
2.6
7.2
|
L
 -99.3%
H
2.6
592.5
|
L
 -100.0%
H
2.6
15732.2
|
L
 -100.0%
H
2.6
786750
|
L
 -100.0%
H
2.6
27168750
|
| Henry Schein |
|
9,089.5
|
77.2
|
L
 -1.6%
H
77.0
78.3
|
L
 -3.5%
H
77.0
79.8
|
L
 1.3%
H
74.1
80.1
|
L
 20.9%
H
62.1
80.1
|
L
 3.0%
H
60.6
82.5
|
L
 -4.4%
H
60.0
89.7
|
L
 11.7%
H
60.0
92.7
|
L
 34.4%
H
41.9
92.7
|
| Hyperfine Inc (Class A) |
|
120.5
|
1.2
|
L
 -0.8%
H
1.2
1.3
|
L
 3.3%
H
1.1
1.3
|
L
 15.9%
H
0.9
1.3
|
L
 -3.1%
H
0.9
1.3
|
L
 25.3%
H
0.5
2.2
|
L
 31.9%
H
0.5
3.3
|
L
H
0.5
16.6
|
L
H
0.5
16.6
|
| Integra Lifesciences Holdings Corp |
|
926.9
|
11.9
|
L
 -2.4%
H
11.7
12.1
|
L
 -4.1%
H
11.7
12.5
|
L
 -6%
H
11.7
14.1
|
L
 -26.2%
H
10.9
16.5
|
L
 -54.3%
H
10.9
27.1
|
L
 -79.0%
H
10.9
60.7
|
L
 -82.8%
H
10.9
77.4
|
L
 -62.2%
H
10.9
77.4
|
| Icecure Medical Ltd |
|
44.1
|
0.6
|
L
 -3.0%
H
0.6
0.7
|
L
 -5.9%
H
0.6
0.7
|
L
 -4.5%
H
0.6
0.7
|
L
 -20%
H
0.6
0.8
|
L
 -48.4%
H
0.6
1.7
|
L
 -54.3%
H
0.5
1.7
|
L
 -65.2%
H
0.5
16
|
L
 -44.3%
H
0.2
16
|
| SeaStar Medical Holding Corp |
|
9.8
|
2.6
|
L
 -0.4%
H
2.5
2.7
|
L
 2.0%
H
2.3
2.7
|
L
 -89.3%
H
2.2
27.9
|
L
 -95.8%
H
2.2
61.4
|
L
 -98.4%
H
2.2
307
|
L
 -100.0%
H
2.2
14775
|
L
H
2.2
55000
|
L
H
2.2
55000
|
| ICU Medical Inc |
|
3,768.9
|
152.7
|
L
 -3.7%
H
150.8
157.3
|
L
 -2.2%
H
150.8
160.3
|
L
 3.9%
H
137.4
160.3
|
L
 23.6%
H
115
160.3
|
L
 -11.4%
H
107
175.5
|
L
 -17.5%
H
78.4
212.4
|
L
 -30.8%
H
78.4
282
|
L
 62.1%
H
78.4
321.7
|
| Idexx Laboratories |
|
55,404.8
|
693.9
|
L
 0.4%
H
687.5
698.3
|
L
 -3.0%
H
681
709.2
|
L
 0.8%
H
661.9
726.4
|
L
 8.3%
H
622.1
770.0
|
L
 59.4%
H
356.3
770.0
|
L
 42.6%
H
356.3
770.0
|
L
 40.8%
H
317.1
770.0
|
L
 945.6%
H
63.5
770.0
|
| Inspira Tech Oxy B.H.N. Ltd |
|
29.8
|
0.8
|
L
H
0.8
0.9
|
L
 -5.7%
H
0.8
0.9
|
L
 -11.7%
H
0.8
1.1
|
L
 -24.6%
H
0.8
1.2
|
L
 -17%
H
0.4
1.7
|
L
 -50.3%
H
0.4
2.5
|
L
H
0.4
9.6
|
L
H
0.4
9.6
|
| Intercure Ltd |
|
50.9
|
0.9
|
L
 -1.1%
H
0.9
0.9
|
L
 -3.1%
H
0.9
1.0
|
L
 -18.4%
H
0.7
1.1
|
L
 -38.4%
H
0.7
1.5
|
L
 -46.6%
H
0.7
1.8
|
L
 -75.1%
H
0.7
4.0
|
L
 -82.0%
H
0.7
12.7
|
L
H
0.7
19.4
|
| Inogen Inc |
|
163.7
|
6.0
|
L
 -3.1%
H
6.0
6.2
|
L
 -3.5%
H
6.0
6.5
|
L
 -9.6%
H
6
7.5
|
L
 -31.2%
H
6
8.9
|
L
 -47.3%
H
5.7
12.9
|
L
 -74.3%
H
4.1
26.1
|
L
 -87.1%
H
4.1
82.4
|
L
 -83.4%
H
4.1
287.8
|
| Inmode Ltd |
|
881.8
|
14.0
|
L
 -0.9%
H
13.9
14.1
|
L
 0.1%
H
13.7
14.2
|
L
 -3.6%
H
13.7
15.7
|
L
 -8.9%
H
13.7
15.7
|
L
 -19.1%
H
13.1
19.8
|
L
 -59.8%
H
13.1
48.3
|
L
 -53.3%
H
13.1
99.3
|
L
H
6.5
99.3
|
| NAYA Biosciences |
|
24.7
|
1.6
|
L
 -7.4%
H
1.6
1.8
|
L
 101.2%
H
1.6
4.6
|
L
 87.4%
H
0.7
4.6
|
L
 -64.7%
H
0.7
5.3
|
L
 -98.8%
H
0.7
144.2
|
L
 -99.9%
H
0.7
4721.5
|
L
 -100.0%
H
0.7
70848
|
L
 -100.0%
H
0.7
141926.4
|
| IRIDEX Corp |
|
26.1
|
1.5
|
L
 2.0%
H
1.5
1.6
|
L
 7.8%
H
1.4
1.7
|
L
 33.3%
H
1.1
1.7
|
L
 38.2%
H
0.9
1.7
|
L
 -7.3%
H
0.8
1.7
|
L
 -31.2%
H
0.8
3.7
|
L
 -69.2%
H
0.8
9.7
|
L
 -83.2%
H
0.8
16.6
|
| Iradimed Corp |
|
1,283.1
|
100.9
|
L
 -2.9%
H
99.6
104.0
|
L
 -1.1%
H
99.6
104.9
|
L
 3.9%
H
94.5
104.9
|
L
 28.5%
H
75.8
104.9
|
L
 66.8%
H
47.5
104.9
|
L
 171.1%
H
33.5
104.9
|
L
 339.7%
H
21.7
104.9
|
L
 382.8%
H
7.9
104.9
|
| iRhythm Tech Inc |
|
5,166.0
|
160.3
|
L
 -2.7%
H
158.9
164.3
|
L
 -4.1%
H
158.9
167.6
|
L
 -8.8%
H
149.9
191.4
|
L
 -11.2%
H
149.9
212
|
L
 44.9%
H
92.5
212
|
L
 61.3%
H
55.9
212
|
L
 -36.6%
H
41.7
286.2
|
L
H
22.2
286.2
|
| Intuitive Surgical |
|
185,752.4
|
524.0
|
L
 -0.4%
H
521.2
540
|
L
 -2.1%
H
518.6
540
|
L
 -9.2%
H
518.6
603.9
|
L
 -4.1%
H
518.6
603.9
|
L
 -10.3%
H
425
609.1
|
L
 103.1%
H
222.7
616
|
L
 111.3%
H
180.1
616
|
L
 733.1%
H
55.8
616
|
| Jowell Global Ltd |
|
4.8
|
2.2
|
L
 -1.4%
H
2.1
2.2
|
L
 2.3%
H
2.1
2.2
|
L
 -4.4%
H
2.0
2.4
|
L
 28.7%
H
1.5
2.5
|
L
 -24.9%
H
1.5
3.2
|
L
 -73.4%
H
1
9.1
|
L
H
1
412.5
|
L
H
1
412.5
|
| Kewaunee Scientific Corp |
|
114.9
|
40.1
|
L
 1.1%
H
38
40.4
|
L
 -0.8%
H
38
40.4
|
L
 5.5%
H
37.1
41.2
|
L
 -11.6%
H
37.0
44.5
|
L
 -34.2%
H
30.3
71.3
|
L
 138.1%
H
14.6
71.3
|
L
 214.4%
H
11.4
71.3
|
L
 141.2%
H
7.0
71.3
|
| OrthoPediatrics corp |
|
454.2
|
18.1
|
L
 -2.1%
H
17.8
18.8
|
L
 -1.3%
H
17.8
19.3
|
L
 4.0%
H
17.1
20.3
|
L
 6.3%
H
15.9
20.3
|
L
 -31.4%
H
15.3
26.4
|
L
 -61.5%
H
15.3
53.5
|
L
 -58.7%
H
15.3
73.9
|
L
H
14
73.9
|
| KORU Medical Systems Inc |
|
259.9
|
5.6
|
L
 -1.2%
H
5.6
5.8
|
L
 1.8%
H
5.5
5.8
|
L
 -13.4%
H
5.1
6.5
|
L
 32.3%
H
3.7
6.6
|
L
 36.2%
H
1.9
6.6
|
L
 48.0%
H
1.9
6.6
|
L
 8.3%
H
1.8
6.6
|
L
 1268.3%
H
0.3
12.8
|
| Standard BioTools Inc |
|
596.1
|
1.6
|
L
 -3.7%
H
1.5
1.6
|
L
 -0.6%
H
1.5
1.7
|
L
 5.4%
H
1.2
1.7
|
L
 9.2%
H
1.1
1.7
|
L
 -6.1%
H
0.9
1.7
|
L
 -23.6%
H
0.9
3.2
|
L
 -77.4%
H
0.9
7.5
|
L
 -76.9%
H
0.9
14.9
|
| LivaNova PLC |
|
3,448.9
|
63.2
|
L
 -1.1%
H
62.5
63.9
|
L
 1.7%
H
60.8
64.8
|
L
 0.1%
H
60.4
65.4
|
L
 15.1%
H
48.8
65.6
|
L
 31.2%
H
32.5
65.6
|
L
 12.0%
H
32.5
65.6
|
L
 -4.9%
H
32.5
93.9
|
L
 18.7%
H
32.5
131.5
|
| Lemaitre Vascular Inc |
|
1,910.6
|
84.2
|
L
 -1.8%
H
83.7
86.5
|
L
 -4.6%
H
83.7
88.2
|
L
 -0.1%
H
79.4
88.4
|
L
 -5.6%
H
79.4
92.3
|
L
 -13.1%
H
71.4
105.6
|
L
 79.6%
H
44.3
109.6
|
L
 85.4%
H
38.3
109.6
|
L
 478.8%
H
12.0
109.6
|
| LENSAR Inc |
|
149.4
|
12.5
|
L
 1.1%
H
12.1
12.6
|
L
 5.1%
H
11.9
12.6
|
L
 4.2%
H
11.2
12.6
|
L
 4.5%
H
9.5
12.7
|
L
 32.8%
H
9.0
17.3
|
L
 384.9%
H
1.8
17.3
|
L
 89.8%
H
1.8
17.3
|
L
H
1.8
17.3
|
| Lantheus Holdings Inc |
|
4,476.7
|
67.5
|
L
 0.5%
H
66.5
67.9
|
L
 5.1%
H
63.4
67.9
|
L
 1.2%
H
63.4
70.3
|
L
 20.4%
H
50.2
70.3
|
L
 -30.8%
H
47.3
111.3
|
L
 23.5%
H
47.3
126.9
|
L
 323.0%
H
15.5
126.9
|
L
 2496.5%
H
1.8
126.9
|
| Lucid Diagnostics Inc |
|
158.6
|
1.2
|
L
 13.1%
H
1.1
1.2
|
L
H
1.1
1.6
|
L
 9.0%
H
1.0
1.6
|
L
 -5.5%
H
1.0
1.6
|
L
 34.4%
H
0.9
1.8
|
L
 0.8%
H
0.6
1.9
|
L
H
0.6
13.5
|
L
H
0.6
13.5
|
| Pulmonx Corp |
|
76.3
|
1.9
|
L
 -3.1%
H
1.9
1.9
|
L
 4.5%
H
1.7
2.0
|
L
 -18.9%
H
1.7
2.4
|
L
 12.8%
H
1.3
2.9
|
L
 -69.7%
H
1.3
9.4
|
L
 -79.0%
H
1.3
14.8
|
L
 -97.2%
H
1.3
68.8
|
L
H
1.3
69.5
|
| Masimo Corp |
|
7,598.4
|
141.5
|
L
 -1.7%
H
141.4
144.6
|
L
 -0.4%
H
138.8
148.8
|
L
 6.1%
H
125.9
148.8
|
L
 -4.3%
H
125.9
157.7
|
L
 -16.9%
H
125.9
194.9
|
L
 -15.6%
H
75.2
198
|
L
 -46.4%
H
75.2
305.2
|
L
 280.4%
H
33.0
305.2
|
| 908 Devices Inc |
|
247.6
|
6.8
|
L
 -2.3%
H
6.8
7.5
|
L
 25.1%
H
6.2
7.5
|
L
 25.5%
H
5.0
7.5
|
L
 -19.6%
H
5.0
9.2
|
L
 162.1%
H
1.9
9.3
|
L
 -24.7%
H
1.8
12.5
|
L
 -89.5%
H
1.8
79.6
|
L
H
1.8
79.6
|
| Mimedx Grp Inc |
|
779.0
|
5.3
|
L
 -3.0%
H
5.3
5.4
|
L
 -3.0%
H
5.1
5.5
|
L
 -25.7%
H
5.1
7.1
|
L
 -22.2%
H
5.1
8.0
|
L
 -40.2%
H
5.1
9.3
|
L
 45.3%
H
3.1
10.1
|
L
 -40.8%
H
2.4
16.0
|
L
 -37.1%
H
1.0
18.3
|
| Mesa Laboratories Inc |
|
456.5
|
82.7
|
L
 -4.4%
H
81.8
85.6
|
L
 -6.8%
H
81.8
88.2
|
L
 2.5%
H
77.0
90.0
|
L
 4.4%
H
69.5
90.0
|
L
 -41.2%
H
55.5
155.1
|
L
 -57.9%
H
55.5
206.4
|
L
 -71.3%
H
55.5
333.4
|
L
 -11.3%
H
55.5
333.4
|
| Merit Medical Systems Inc |
|
4,841.6
|
81.7
|
L
 -2.1%
H
80.3
83.4
|
L
 -0.8%
H
80.3
84.6
|
L
 -6.6%
H
79.7
94.8
|
L
 -1.3%
H
79.7
94.8
|
L
 -22.0%
H
78.1
111.5
|
L
 17.1%
H
62.6
111.5
|
L
 41.3%
H
50.5
111.5
|
L
 399.4%
H
15.6
111.5
|
| Modular Medical Inc |
|
36.5
|
0.5
|
L
H
0.5
0.5
|
L
 -2.1%
H
0.5
0.5
|
L
 17.5%
H
0.4
0.5
|
L
 -14.6%
H
0.3
0.6
|
L
 -63.9%
H
0.3
1.3
|
L
 -82.8%
H
0.3
3.8
|
L
 -96.7%
H
0.3
19.5
|
L
 -42.0%
H
0.3
19.5
|
| Myriad Genetics Inc |
|
547.2
|
5.9
|
L
 -3.1%
H
5.7
6.0
|
L
 -0.8%
H
5.5
6.2
|
L
 -10.4%
H
5.5
7.2
|
L
 -28.0%
H
5.5
8.5
|
L
 -54.2%
H
3.8
15.5
|
L
 -72.0%
H
3.8
29.3
|
L
 -78.0%
H
3.8
37.0
|
L
 -85.4%
H
3.8
50.4
|
| MDxHealth SA (ADR) |
|
-
|
3.8
|
L
 -8.7%
H
3.8
4.2
|
L
 -1.3%
H
3.6
4.3
|
L
 9.2%
H
3
4.3
|
L
 -14.6%
H
2.8
5.3
|
L
 89.5%
H
1.4
5.3
|
L
 -46.3%
H
1.4
7.6
|
L
H
1.4
13.2
|
L
H
1.4
13.2
|
| ENvue Medical Inc |
|
1.2
|
1.1
|
L
 -5.2%
H
1.1
1.2
|
L
 -16.0%
H
1.1
1.3
|
L
 -60.4%
H
1.1
3
|
L
 -81.0%
H
1.1
6.0
|
L
 -97.6%
H
0.7
162.5
|
L
 -99.8%
H
0.7
836
|
L
 -100.0%
H
0.7
9218
|
L
 -100.0%
H
0.7
18700
|
| ENDRA Life Sciences Inc |
|
5.2
|
4.5
|
L
 -5.1%
H
4.4
4.6
|
L
 -6.9%
H
4.2
4.8
|
L
 -12.8%
H
4.2
5.1
|
L
 -11%
H
4.1
7.0
|
L
 -21.0%
H
2.9
12.0
|
L
 -97.9%
H
0.0
220
|
L
 -99.8%
H
0.0
3100
|
L
H
0.0
5880
|
| Neogen Corp |
|
2,131.8
|
9.8
|
L
 -1.2%
H
9.7
10.0
|
L
 6.0%
H
8.9
10.1
|
L
 37.3%
H
6.9
10.3
|
L
 58.3%
H
5.4
10.3
|
L
 -14.6%
H
3.9
12.0
|
L
 -50.6%
H
3.9
24.1
|
L
 -77.3%
H
3.9
48.9
|
L
 -49.8%
H
3.9
48.9
|
| Nephros Inc |
|
49.7
|
4.7
|
L
 0.4%
H
4.6
4.8
|
L
 4.5%
H
4.3
5.1
|
L
 -10.5%
H
4.2
5.5
|
L
 -10.5%
H
3.7
6.4
|
L
 185.4%
H
1.4
6.4
|
L
 246.7%
H
1.0
6.4
|
L
 -40%
H
0.9
11.7
|
L
 30%
H
0.9
11.7
|
| NeuroOne Medical Tech Corp |
|
43.4
|
0.9
|
L
 -1.2%
H
0.9
0.9
|
L
 -4.4%
H
0.9
0.9
|
L
 11.7%
H
0.7
1.0
|
L
 4.9%
H
0.6
1.0
|
L
 -28.3%
H
0.4
1.3
|
L
 -39.0%
H
0.4
2.2
|
L
 -87.9%
H
0.4
13.5
|
L
H
0.4
30
|
| Nano X Imaging Ltd |
|
215.8
|
3.3
|
L
 6.1%
H
3.0
3.3
|
L
 4.8%
H
2.9
3.3
|
L
 10.7%
H
2.8
3.3
|
L
 -18.7%
H
2.8
4.7
|
L
 -60.0%
H
2.8
8.1
|
L
 -62.6%
H
2.8
22.7
|
L
 -95.0%
H
2.8
94.8
|
L
H
2.8
94.8
|
| NeuroPace Inc |
|
556.6
|
16.7
|
L
 -1.9%
H
16.7
17.1
|
L
 -1.4%
H
16.2
17.4
|
L
 3.2%
H
15.0
17.9
|
L
 59.5%
H
9.2
17.9
|
L
 13.8%
H
7.6
19.0
|
L
 374.7%
H
3.0
19.0
|
L
H
1.2
27.4
|
L
H
1.2
27.4
|
| InspireMD Inc |
|
68.6
|
1.6
|
L
 -5.3%
H
1.6
1.7
|
L
 1.9%
H
1.5
1.7
|
L
 -21.0%
H
1.5
2.2
|
L
 -28.3%
H
1.5
2.4
|
L
 -42.8%
H
1.5
3.8
|
L
 40.9%
H
1.0
3.9
|
L
 -84.5%
H
0.8
22.2
|
L
 -100.0%
H
0.8
622059.4
|
| Nortech Systems Inc |
|
24.4
|
8.8
|
L
H
8.4
8.8
|
L
 4.3%
H
8.2
8.8
|
L
 19.2%
H
7.3
8.8
|
L
 -9.8%
H
6.5
9.9
|
L
 -15.1%
H
6.5
12.4
|
L
 -35.1%
H
6.5
19.2
|
L
 20.8%
H
5.5
19.6
|
L
 132.4%
H
1.7
19.6
|
| Natera Inc |
|
33,688.1
|
241.6
|
L
 -0.6%
H
240.6
249.3
|
L
 4.5%
H
226.7
250
|
L
 2.6%
H
225.8
256.4
|
L
 25.5%
H
182.2
256.4
|
L
 44.1%
H
125.4
256.4
|
L
 462.6%
H
36.9
256.4
|
L
 101.7%
H
26.1
256.4
|
L
 2566.4%
H
6.5
256.4
|
| Nutriband Inc |
|
58.4
|
4.8
|
L
 6.2%
H
4.4
4.9
|
L
 10.1%
H
4.3
4.9
|
L
 1.3%
H
4.2
6.4
|
L
 -32.9%
H
4.2
8.3
|
L
 -43.7%
H
4.2
11.7
|
L
 43.3%
H
1.5
11.8
|
L
 -60.7%
H
0.9
27.4
|
L
H
0.9
43.5
|
| Nuwellis Inc |
|
2.0
|
2.2
|
L
 4.7%
H
2.0
2.3
|
L
 16.8%
H
1.7
2.3
|
L
 7.8%
H
1.7
2.9
|
L
 -31.7%
H
1.7
4
|
L
 -96.0%
H
1.7
70.1
|
L
 -100.0%
H
1.7
16008.3
|
L
 -100.0%
H
1.7
1819771.8
|
L
 -100.0%
H
1.7
10000000000
|
| NovoCure Ltd |
|
1,506.2
|
13.5
|
L
 -5.2%
H
13.4
14.1
|
L
 -1.4%
H
12.8
14.3
|
L
 0.1%
H
12.8
15.2
|
L
 -2.2%
H
10.7
15.2
|
L
 -48.9%
H
10.7
26.5
|
L
 -84.7%
H
10.7
95.9
|
L
 -92.0%
H
10.7
232.8
|
L
 -2.6%
H
6.0
232.8
|
| enVVeno Medical Corp |
|
7.7
|
11.7
|
L
 7.1%
H
10.5
12
|
L
 -2.3%
H
9.8
12.8
|
L
 -5.9%
H
9.8
13.8
|
L
 -53.1%
H
9.8
26.3
|
L
 -90.1%
H
9.8
196.7
|
L
 -93.2%
H
9.8
244.0
|
L
 -96.2%
H
9.8
398.3
|
L
H
9.8
4935
|
| Nexalin Tech Inc |
|
11.2
|
0.6
|
L
 -4.8%
H
0.6
0.7
|
L
 -13.0%
H
0.6
0.7
|
L
 -13.0%
H
0.5
0.8
|
L
 -58.3%
H
0.5
1.7
|
L
 -77.9%
H
0.5
3.9
|
L
 -43.4%
H
0.3
4.5
|
L
H
0.3
4.5
|
L
H
0.3
4.5
|
| Nyxoah SA |
|
201.8
|
4.7
|
L
 -2.3%
H
4.7
5.0
|
L
 -6.4%
H
4.7
5
|
L
 0.9%
H
4.5
5.4
|
L
 -16.4%
H
4.4
5.9
|
L
 -56.6%
H
4.3
11.9
|
L
 -16.3%
H
4
20
|
L
H
4
37
|
L
H
4
37
|
| Nanobiotix (ADR) |
|
1,013.2
|
20.9
|
L
 -2.1%
H
20.9
21.2
|
L
 -0.2%
H
19.8
21.4
|
L
 -7.6%
H
19.6
23.7
|
L
 9.1%
H
14.8
24.0
|
L
 507.0%
H
3.0
30.4
|
L
 378.1%
H
1.8
30.4
|
L
 10.2%
H
1.8
30.4
|
L
H
1.8
30.4
|
| Orchestra BioMed Holdings Inc |
|
228.1
|
4.0
|
L
 -2.2%
H
4.0
4.4
|
L
 -4.3%
H
3.9
4.4
|
L
 -6.7%
H
3.9
5
|
L
 2.0%
H
3.5
5.4
|
L
 -24.2%
H
2.2
6.2
|
L
 -60.4%
H
2.2
23.4
|
L
 -67.7%
H
2.2
23.4
|
L
H
2.2
23.4
|
| Orthofix Medical Inc |
|
527.9
|
13.3
|
L
 -3.6%
H
13.2
13.8
|
L
 -5.1%
H
13.2
14.2
|
L
 -12.1%
H
13.2
16.4
|
L
 -16.5%
H
13.2
17.0
|
L
 -27.4%
H
10.2
20.5
|
L
 -35.5%
H
9.6
22.6
|
L
 -69.7%
H
9.6
48.5
|
L
 -65.7%
H
9.6
74.4
|
| Outset Medical Inc |
|
92.8
|
5.1
|
L
 -5.4%
H
5.1
5.4
|
L
 -3.6%
H
5
5.6
|
L
 55.3%
H
3.1
6.5
|
L
 -65.4%
H
3.1
14.9
|
L
 -60.0%
H
0.5
22.0
|
L
 -98.8%
H
0.5
458.3
|
L
 -99.4%
H
0.5
915
|
L
H
0.5
1004.4
|
| Organogenesis Holdings Inc (Class A) |
|
497.5
|
3.9
|
L
 -2%
H
3.9
4.0
|
L
 3.4%
H
3.6
4.1
|
L
 -33.2%
H
3.6
5.7
|
L
 -8.0%
H
3.6
7.1
|
L
 10.1%
H
2.6
7.1
|
L
 51.9%
H
1.8
7.1
|
L
 -62.9%
H
1.8
24.3
|
L
H
1.8
310.9
|
| Orasure Tech Inc |
|
191.5
|
2.7
|
L
 -1.8%
H
2.6
2.8
|
L
 -0.7%
H
2.6
2.8
|
L
 9.9%
H
2.3
2.8
|
L
 -9.8%
H
2.1
3
|
L
 -33.4%
H
2.1
4.2
|
L
 -47.4%
H
2.1
8.5
|
L
 -80.7%
H
2.1
15.9
|
L
 -52.9%
H
2.1
23.0
|
| Pacific Biosciences of California Inc |
|
778.9
|
2.6
|
L
 -3.4%
H
2.6
2.7
|
L
 16.7%
H
2.1
2.7
|
L
 37.2%
H
1.7
2.7
|
L
 27.7%
H
1.5
2.7
|
L
 52.7%
H
0.9
2.7
|
L
 -76.2%
H
0.9
14.6
|
L
 -93.1%
H
0.9
53.7
|
L
 -79.8%
H
0.9
53.7
|
| PAVmed Inc |
|
8.4
|
9.2
|
L
 -16.6%
H
9.0
10.5
|
L
 39.2%
H
6.1
28.4
|
L
 6.0%
H
6
28.4
|
L
 -25.2%
H
6
28.4
|
L
 -52.9%
H
6
28.4
|
L
 -95.7%
H
6
280.8
|
L
 -99.1%
H
6
4365
|
L
H
6
6858
|
| Pro-Dex Inc (co) |
|
127.6
|
39.1
|
L
 -3.2%
H
38.5
40
|
L
 -7.4%
H
38.5
42.3
|
L
 -3.2%
H
36.6
43.7
|
L
 37.8%
H
28.4
47.4
|
L
 -3.8%
H
23.5
70.3
|
L
 130.8%
H
14.5
70.3
|
L
 20.7%
H
12.4
70.3
|
L
 1536.8%
H
2.3
70.3
|
| Pulse Biosciences Inc |
|
1,022.6
|
15.1
|
L
 3.7%
H
14.5
15.3
|
L
 5.9%
H
13.8
15.3
|
L
 1.6%
H
13.2
15.6
|
L
 -16.5%
H
12.6
18.3
|
L
 -16.7%
H
12.6
25
|
L
 406.4%
H
2.4
25
|
L
 -48.9%
H
1.2
45.8
|
L
H
1.2
45.8
|
| Axe Compute Inc |
|
18.7
|
5.5
|
L
 -8.0%
H
5.5
6.0
|
L
 -14.3%
H
5.3
6.4
|
L
 -8.9%
H
5.3
9
|
L
 -31.2%
H
3.9
10.1
|
L
 -75.0%
H
3.9
39
|
L
 -95.7%
H
3.9
208.2
|
L
 -98.6%
H
3.9
690
|
L
 -100.0%
H
3.9
285000
|
| Precision Optics Corp Inc |
|
39.1
|
5.1
|
L
 0.2%
H
5.0
5.2
|
L
 15.2%
H
4.3
5.3
|
L
 23.7%
H
4.0
5.3
|
L
 17.9%
H
4.0
5.3
|
L
 -0.6%
H
3.8
5.3
|
L
 -15.5%
H
3.5
7.2
|
L
H
3.5
7.9
|
L
H
3.5
7.9
|
| Insulet |
|
19,106.2
|
271.6
|
L
 -3%
H
265.8
279.9
|
L
 -5.6%
H
265.8
289.0
|
L
 -6.0%
H
265.8
299.8
|
L
 -15.4%
H
265.8
354.9
|
L
 -3.1%
H
230.1
354.9
|
L
 -6.9%
H
125.8
354.9
|
L
 -6.4%
H
125.8
354.9
|
L
 714.4%
H
23.9
354.9
|
| Procept BioRobotics Corp |
|
1,627.7
|
29.1
|
L
 -5.2%
H
29.1
30.7
|
L
 -4.1%
H
29.1
32.1
|
L
 -11.4%
H
29.1
35.4
|
L
 -16.8%
H
27.8
38.1
|
L
 -60.4%
H
27.8
76.4
|
L
 -25.7%
H
24.8
103.8
|
L
H
15.4
103.8
|
L
H
15.4
103.8
|
| Prenetics Global Ltd (Class A) |
|
310.0
|
18.4
|
L
 -2.5%
H
17.5
18.9
|
L
 17.2%
H
15.1
19.0
|
L
 8.9%
H
14.1
19.0
|
L
 9.9%
H
11.4
19.0
|
L
 233.7%
H
3.1
19.0
|
L
 -21.8%
H
2.9
24.5
|
L
H
2.9
131.3
|
L
H
2.9
131.3
|
| Profound Medical Corp |
|
288.9
|
8.0
|
L
 3.0%
H
7.4
8.1
|
L
 -3.2%
H
7.4
8.3
|
L
 6.0%
H
7
9.0
|
L
 44.7%
H
5.4
9.0
|
L
 12.9%
H
3.8
9.0
|
L
 -38.0%
H
3.8
15.5
|
L
 -69.3%
H
3.1
29.0
|
L
H
0.0
29.0
|
| QuidelOrtho Corporation |
|
1,908.2
|
28.1
|
L
 -8.1%
H
28.0
30.2
|
L
 -15.4%
H
27.2
33.4
|
L
 -2.8%
H
27.2
35.6
|
L
 -7.9%
H
19.5
35.6
|
L
 -36.5%
H
19.5
46.2
|
L
 -67.6%
H
19.5
98.7
|
L
 -88.0%
H
19.5
265
|
L
 65.8%
H
13.2
306.7
|
| Quanterix Corp |
|
302.7
|
6.5
|
L
 -10.3%
H
6.4
7.2
|
L
 -12.4%
H
6.4
7.5
|
L
 -2.1%
H
6.2
8.8
|
L
 13.3%
H
4.5
8.8
|
L
 -32.3%
H
4.1
10.0
|
L
 -55.2%
H
4.1
29.7
|
L
 -91.7%
H
4.1
92.6
|
L
H
4.1
92.6
|
| AVITA Medical Inc |
|
135.4
|
4.4
|
L
 7.5%
H
4.2
4.6
|
L
 13.9%
H
3.7
4.6
|
L
 26.1%
H
3.2
4.6
|
L
 11.8%
H
3.2
4.6
|
L
 -52.4%
H
3.2
11.3
|
L
 -46.8%
H
3.2
21.7
|
L
 -83.7%
H
3.2
28.5
|
L
 -35.7%
H
3.2
55.4
|
| Rockwell Medical Inc |
|
45.3
|
1.2
|
L
 2.7%
H
1.1
1.2
|
L
 19.8%
H
1.1
1.3
|
L
 42.0%
H
0.8
1.3
|
L
 -0.9%
H
0.8
1.3
|
L
 -47.7%
H
0.8
2.2
|
L
 -43.9%
H
0.8
6.2
|
L
 -92.6%
H
0.8
21.8
|
L
 -98.6%
H
0.8
116.4
|
| Vyome Holdings Inc |
|
18.0
|
3.2
|
L
 9.3%
H
2.9
3.3
|
L
 11.9%
H
2.7
3.3
|
L
 -15.2%
H
2.7
3.8
|
L
 -41.9%
H
2.7
6.6
|
L
 -28.2%
H
0.3
12.9
|
L
 -99.3%
H
0.3
1299.2
|
L
 -100.0%
H
0.3
52200
|
L
H
0.3
1381560
|
| Rewalk Robotics Ltd |
|
40.3
|
0.7
|
L
 -2.9%
H
0.7
0.7
|
L
 -2.9%
H
0.7
0.8
|
L
 6.4%
H
0.6
0.8
|
L
 3.1%
H
0.5
0.8
|
L
 -48.5%
H
0.5
1.3
|
L
 -89.0%
H
0.5
9.1
|
L
 -96.4%
H
0.5
42
|
L
 -100.0%
H
0.5
2135
|
| Sanmina Corp |
|
9,703.1
|
177.8
|
L
 -0.9%
H
173.5
184.7
|
L
 0.2%
H
171.0
185.3
|
L
 15.5%
H
144
185.3
|
L
 32.9%
H
133.0
185.3
|
L
 111.7%
H
63.7
185.3
|
L
 193.3%
H
43.4
185.3
|
L
 416.9%
H
30.6
185.3
|
L
 930.3%
H
17.0
185.3
|
| Sight Sciences Inc |
|
318.3
|
6.0
|
L
 -6.2%
H
6
6.4
|
L
 -7.0%
H
6.0
6.7
|
L
 -33.5%
H
6.0
9.2
|
L
 14.0%
H
4.9
9.2
|
L
 105.5%
H
2.0
9.2
|
L
 -51.7%
H
1.0
13.3
|
L
H
1.0
42.6
|
L
H
1.0
42.6
|
| Sotera Health Co |
|
5,258.6
|
18.5
|
L
 -2.1%
H
18.5
19.1
|
L
 -3.5%
H
18.5
19.2
|
L
 4.6%
H
17.5
19.9
|
L
 9.8%
H
15.0
19.9
|
L
 35.6%
H
9.5
19.9
|
L
 10.0%
H
9.5
19.9
|
L
 -30.9%
H
5.8
30.4
|
L
H
5.8
30.4
|
| SI-BONE Inc |
|
729.0
|
16.8
|
L
 -0.7%
H
16.4
17.2
|
L
 -1.2%
H
16.4
17.3
|
L
 -17.5%
H
16.4
21.9
|
L
 8.5%
H
14.5
21.9
|
L
 3.4%
H
12.5
21.9
|
L
 -3.9%
H
11.7
29.5
|
L
 -46.2%
H
11.1
37.2
|
L
H
7.2
37.2
|
| SINTX Tech Inc |
|
13.5
|
3.5
|
L
 -1.4%
H
3.5
3.6
|
L
 -6.2%
H
3.5
3.8
|
L
 -0.9%
H
3.5
4.1
|
L
 -6.4%
H
3.0
4.5
|
L
 9.4%
H
1.7
7.4
|
L
 -99.8%
H
0.1
2428
|
L
 -100.0%
H
0.1
68800
|
L
 -100.0%
H
0.1
26064000
|
| Beauty Health Co (Class A) |
|
195.1
|
1.5
|
L
 -1.9%
H
1.5
1.6
|
L
 2%
H
1.4
1.6
|
L
 5.5%
H
1.4
1.6
|
L
 10.1%
H
1.2
1.7
|
L
 -11.6%
H
0.8
2.7
|
L
 -86.1%
H
0.8
13.9
|
L
 -86.2%
H
0.8
30.2
|
L
H
0.8
30.2
|
| Sanara MedTech Inc |
|
194.4
|
21.8
|
L
 -2.3%
H
21.2
23.0
|
L
 -4.8%
H
21.2
23.0
|
L
 -11.3%
H
21.2
26.0
|
L
 -30.0%
H
18.9
31
|
L
 -41.4%
H
18.9
37.9
|
L
 -51.6%
H
18.9
50.2
|
L
 -48.9%
H
17.4
50.2
|
L
 268.6%
H
2
75
|
| Sensus Healthcare Inc |
|
79.3
|
4.8
|
L
 -2.8%
H
4.7
5.0
|
L
 -8.9%
H
4.7
5.3
|
L
 27.4%
H
3.7
5.5
|
L
 44.6%
H
3.1
5.5
|
L
 -32.4%
H
3.0
9.1
|
L
 -46.5%
H
1.8
9.3
|
L
 26.8%
H
1.8
15.3
|
L
H
1.8
15.3
|
| STRATA Skin Sciences Inc |
|
7.5
|
1.3
|
L
 -2.3%
H
1.3
1.3
|
L
 -2.3%
H
1.3
1.3
|
L
H
1.2
1.5
|
L
 -25.7%
H
1.2
2.3
|
L
 -57.4%
H
1.2
3.9
|
L
 -85.2%
H
1.2
41
|
L
 -93.3%
H
1.2
41
|
L
 -97.7%
H
1.2
76.5
|
| Staar Surgical Co. |
|
944.9
|
19.1
|
L
 -3.8%
H
19.1
20
|
L
 -8.7%
H
19.1
21.3
|
L
 -19%
H
19.1
24.3
|
L
 -27.1%
H
19.1
28.4
|
L
 -21.7%
H
13.5
30.8
|
L
 -72.2%
H
13.5
81.8
|
L
 -79.1%
H
13.5
163.1
|
L
 178.2%
H
5.0
163.1
|
| Neuronetics Inc |
|
145.9
|
2.1
|
L
 -3.2%
H
2.1
2.3
|
L
 12.1%
H
1.8
2.3
|
L
 50%
H
1.3
2.3
|
L
 -31.7%
H
1.3
3.2
|
L
 -12.7%
H
1.3
5.9
|
L
 -63.8%
H
0.5
6.6
|
L
 -90.0%
H
0.5
22.4
|
L
H
0.5
39.4
|
| Star Equity Holdings Inc |
|
32.7
|
10.1
|
L
 -4.8%
H
10.0
10.4
|
L
 -7.5%
H
10.0
10.9
|
L
 -7.2%
H
10.0
11.5
|
L
 -8.0%
H
9.3
11.5
|
L
 360.9%
H
1.7
12.0
|
L
 124.8%
H
1.7
12.0
|
L
 -47.5%
H
1.7
27
|
L
 -96.0%
H
1.7
307.5
|
| Sharps Tech Inc |
|
62.9
|
2.2
|
L
 -1.4%
H
2.1
2.2
|
L
 -8.4%
H
2.1
2.3
|
L
 -1.4%
H
1.7
2.6
|
L
 -57.0%
H
1.7
5.5
|
L
 -99.6%
H
0.0
519
|
L
 -100.0%
H
0.0
13464
|
L
H
0.0
23892
|
L
H
0.0
23892
|
| Tactile Systems Tech Inc |
|
647.3
|
29.0
|
L
 -3.0%
H
28.5
29.9
|
L
 -4.9%
H
28.5
31.4
|
L
 -1.3%
H
26.9
31.4
|
L
 91.9%
H
14.8
31.4
|
L
 66.7%
H
8.6
31.4
|
L
 131.3%
H
8.6
31.4
|
L
 -44.9%
H
6.3
64.5
|
L
H
6.3
76.6
|
| TELA Bio Inc |
|
43.6
|
1.0
|
L
 2.1%
H
1.0
1
|
L
 -3.9%
H
0.9
1.0
|
L
 -14.0%
H
0.9
1.2
|
L
 -33.8%
H
0.9
1.5
|
L
 -63.3%
H
0.9
3.0
|
L
 -91.8%
H
0.9
12.3
|
L
 -93.4%
H
0.9
18
|
L
H
0.9
23.5
|
| Tivic Health Systems Inc |
|
3.2
|
1.3
|
L
 -2.3%
H
1.2
1.3
|
L
 2.5%
H
1.2
1.3
|
L
 -33.9%
H
1.2
1.9
|
L
 -56.8%
H
1.2
2.9
|
L
 -73.4%
H
1.2
15.6
|
L
 -99.9%
H
1.2
1444.8
|
L
H
1.2
11050
|
L
H
1.2
11050
|
| Treace Medical Concepts Inc |
|
164.4
|
2.6
|
L
 -4.1%
H
2.6
2.7
|
L
 -2.3%
H
2.6
2.7
|
L
 5.7%
H
2.4
3.1
|
L
 -62.5%
H
2.4
6.9
|
L
 -72.0%
H
2.4
10.8
|
L
 -90.1%
H
2.4
28.0
|
L
H
2.4
37.2
|
L
H
2.4
37.2
|
| Transmedics Grp Inc |
|
4,623.8
|
135.3
|
L
 -2.0%
H
135.0
139.0
|
L
 -5.6%
H
132.0
145.1
|
L
 6.5%
H
120.2
151.9
|
L
 3.7%
H
111.0
156
|
L
 122.5%
H
59.2
156
|
L
 100.7%
H
36.4
177.4
|
L
 469.2%
H
10
177.4
|
L
H
10
177.4
|
| Tandem Diabetes Care Inc |
|
1,349.3
|
19.9
|
L
 -3.4%
H
19.8
20.8
|
L
 -1.3%
H
19.6
21.6
|
L
 -11.5%
H
19.6
24.0
|
L
 33.1%
H
13.2
24.5
|
L
 -45.5%
H
10.0
37.9
|
L
 -52.2%
H
10.0
53.7
|
L
 -79.8%
H
10.0
155.9
|
L
 -77.2%
H
2.1
155.9
|
| Trinity Biotech PLC (ADR) |
|
16.8
|
0.9
|
L
 13.9%
H
0.8
0.9
|
L
 30.4%
H
0.7
0.9
|
L
 -11.8%
H
0.7
1.1
|
L
 -10%
H
0.7
1.8
|
L
 -95.4%
H
0.7
86
|
L
 -99.9%
H
0.7
775
|
L
 -100.0%
H
0.7
4262.5
|
L
 -100.0%
H
0.7
8550
|
| Utah Medical Products Inc |
|
196.2
|
61.3
|
L
 -1.4%
H
59.7
61.6
|
L
 0.2%
H
59.7
64.0
|
L
 8.8%
H
55.8
64.0
|
L
 1.4%
H
53.7
64.0
|
L
 -2.7%
H
51.3
65.6
|
L
 -31.7%
H
51.3
100.6
|
L
 -29.8%
H
51.3
133.9
|
L
 4.4%
H
51.3
133.9
|
| Vivani Medical Inc |
|
108.0
|
1.5
|
L
 0.7%
H
1.4
1.5
|
L
 16.5%
H
1.3
1.6
|
L
 11.3%
H
1.2
1.6
|
L
 -8.6%
H
1.2
1.8
|
L
 20.3%
H
0.9
1.9
|
L
 25.4%
H
0.8
7.8
|
L
 -74.6%
H
0.8
60
|
L
 -98.5%
H
0.8
166.3
|
| Veracyte Inc |
|
3,341.4
|
42.3
|
L
 -3.5%
H
41.8
43.7
|
L
 1.7%
H
40.4
45.6
|
L
 -1.2%
H
40.3
46.8
|
L
 15.1%
H
34.8
50.7
|
L
 -3.5%
H
22.6
50.7
|
L
 63.4%
H
18.6
50.7
|
L
 -23.5%
H
14.9
86.0
|
L
 553.3%
H
4.2
86.0
|
| Venus Concept Inc |
|
3.0
|
1.6
|
L
H
1.4
1.9
|
L
 -79.8%
H
1.4
5.1
|
L
 -8.0%
H
1.4
12.9
|
L
 -27.4%
H
1.4
12.9
|
L
 362.9%
H
0.3
14.5
|
L
 -69.2%
H
0.3
14.5
|
L
 -95.4%
H
0.3
51.6
|
L
H
0.3
2688.8
|
| Varex Imaging Corp |
|
580.6
|
13.9
|
L
 -3.6%
H
13.8
14.3
|
L
 0.4%
H
13.5
14.6
|
L
 14.1%
H
11.5
14.6
|
L
 15.5%
H
9.8
14.6
|
L
 -2.7%
H
6.8
15.5
|
L
 -35.3%
H
6.8
23.9
|
L
 -31.7%
H
6.8
32.7
|
L
H
6.8
43.8
|
| Vivos Therapeutics Inc |
|
20.2
|
1.8
|
L
 -3.3%
H
1.7
1.9
|
L
 -14.5%
H
1.7
2.1
|
L
 -14.1%
H
1.7
2.7
|
L
 -41.2%
H
1.7
3.1
|
L
 -62.8%
H
1.7
8.0
|
L
 -94.5%
H
1.7
48.8
|
L
 -98.9%
H
1.7
271.5
|
L
H
1.7
360.3
|
| Wrap Tech Inc |
|
125.3
|
2.4
|
L
 -5.8%
H
2.4
2.6
|
L
 -12.9%
H
2.4
2.8
|
L
 12.5%
H
2.1
3.2
|
L
 -12.3%
H
1.9
3.2
|
L
 10.0%
H
1.2
3.2
|
L
 10.0%
H
1.0
7.0
|
L
 -52.9%
H
1.0
9.8
|
L
H
1.0
14.4
|
| Beyond Air Inc |
|
13.8
|
1.6
|
L
 -8.5%
H
1.6
1.8
|
L
 -4.7%
H
1.6
2.3
|
L
 97.6%
H
0.7
2.7
|
L
 -24.3%
H
0.7
2.7
|
L
 -81.3%
H
0.7
10.4
|
L
 -98.7%
H
0.7
154.8
|
L
 -98.7%
H
0.7
328.2
|
L
H
0.7
900
|
| DENTSPLY Sirona Inc |
|
2,540.3
|
12.7
|
L
 -2.1%
H
12.6
13.0
|
L
 4.3%
H
12.0
13.0
|
L
 15.1%
H
11.0
13.0
|
L
 -2.9%
H
9.9
13.3
|
L
 -34.8%
H
9.9
20.6
|
L
 -64.5%
H
9.9
43.2
|
L
 -77.8%
H
9.9
69.5
|
L
 -77.9%
H
9.9
69.5
|
| X.T.L. Biopharma Ltd (ADR) |
|
10.0
|
1.1
|
L
 1.0%
H
1.0
1.1
|
L
 7.1%
H
0.9
1.1
|
L
 35.9%
H
0.5
1.4
|
L
 -78.5%
H
0.5
5.1
|
L
 -85.7%
H
0.5
10.3
|
L
 -80.5%
H
0.5
20.0
|
L
 -92.4%
H
0.5
26.8
|
L
 -96.1%
H
0.5
31.8
|
| 111 Inc (ADR) |
|
44.5
|
5.1
|
L
 -3.8%
H
4.8
5.6
|
L
 -9.2%
H
4.8
5.8
|
L
 66.0%
H
2.5
6.9
|
L
 14.5%
H
2.5
6.9
|
L
 -2.8%
H
2.5
11.3
|
L
 61.3%
H
0.4
11.3
|
L
 -56.9%
H
0.4
45.9
|
L
H
0.4
45.9
|
| Jin Medical Intl Ltd |
|
20.4
|
0.1
|
L
H
0.1
0.2
|
L
 -13.3%
H
0.1
0.2
|
L
 -38.1%
H
0.1
0.3
|
L
 -61.8%
H
0.1
0.4
|
L
 -85.4%
H
0.1
1.0
|
L
H
0.1
509.9
|
L
H
0.1
509.9
|
L
H
0.1
509.9
|
| HeartBeam Inc |
|
62.3
|
1.8
|
L
 -3.2%
H
1.8
1.9
|
L
 -13.0%
H
1.8
2.1
|
L
 -30.1%
H
1.8
2.9
|
L
 9.7%
H
0.5
4
|
L
 -14.6%
H
0.5
4
|
L
 14.6%
H
0.5
4
|
L
 14.6%
H
0.5
4
|
L
 14.6%
H
0.5
4
|
| Cencora |
|
68,761.1
|
353.5
|
L
 0.3%
H
347.6
353.6
|
L
 -0.4%
H
342.7
359.0
|
L
 4.0%
H
329.1
359.0
|
L
 6.2%
H
329.1
377.5
|
L
 42.3%
H
237.7
377.5
|
L
 119.0%
H
147.5
377.5
|
L
 228.0%
H
100.7
377.5
|
L
 288.4%
H
68.4
377.5
|
| Incannex Healthcare Ltd (ADR) |
|
117.7
|
0.3
|
L
 -5.6%
H
0.3
0.4
|
L
 -10.5%
H
0.3
0.4
|
L
 -17.1%
H
0.3
0.4
|
L
 -2.9%
H
0.3
0.5
|
L
 -80.6%
H
0.1
2.3
|
L
 -93.8%
H
0.1
5.3
|
L
 -93.8%
H
0.1
5.3
|
L
 -93.8%
H
0.1
5.3
|
| Rewalk Robotics Ltd |
|
12.3
|
0.7
|
L
 -2.9%
H
0.7
0.7
|
L
 -2.9%
H
0.7
0.8
|
L
 6.4%
H
0.6
0.8
|
L
 3.1%
H
0.5
0.8
|
L
 -58.6%
H
0.5
3.0
|
L
 -89.0%
H
0.5
9.1
|
L
 -96.4%
H
0.5
42
|
L
 -100.0%
H
0.5
2135
|
| Work Medical Tech Grp Ltd |
|
2.3
|
1.9
|
L
 -9.7%
H
1.9
2.1
|
L
 -22.5%
H
1.9
2.4
|
L
 -43.6%
H
1.9
5.9
|
L
 -99.4%
H
1.9
836
|
L
 -100%
H
1.9
60000
|
L
H
1.9
84460
|
L
H
1.9
84460
|
L
H
1.9
84460
|
| iTonic Holdings Ordinary |
|
9.0
|
0.5
|
L
 1.9%
H
0.5
0.6
|
L
 -13.1%
H
0.5
0.6
|
L
 12.8%
H
0.4
1.1
|
L
 -13.1%
H
0.4
1.1
|
L
 -85.2%
H
0.4
32
|
L
H
0.4
32
|
L
H
0.4
32
|
L
H
0.4
32
|
| Ceribell Inc |
|
827.6
|
22.3
|
L
 -1.7%
H
22.2
22.7
|
L
 1.7%
H
21.4
22.8
|
L
 4.2%
H
20.4
24.3
|
L
 73.1%
H
10.9
24.3
|
L
 -2.8%
H
10.0
26.0
|
L
H
10.0
32.8
|
L
H
10.0
32.8
|
L
H
10.0
32.8
|
| Anteris Tech Global Corp |
|
627.4
|
6.5
|
L
 -1.7%
H
6.2
6.6
|
L
 26.4%
H
4.9
6.8
|
L
 19.4%
H
4.4
6.8
|
L
 29.2%
H
3.3
6.8
|
L
 7.9%
H
2.3
8.8
|
L
H
2.3
8.8
|
L
H
2.3
8.8
|
L
H
2.3
8.8
|
| Beta Bionics Inc |
|
702.6
|
16.0
|
L
 -3.3%
H
15.8
16.6
|
L
 -13.7%
H
15.8
19.0
|
L
 -48.7%
H
15.8
32.6
|
L
 -23.8%
H
15.8
32.7
|
L
H
8.9
32.7
|
L
H
8.9
32.7
|
L
H
8.9
32.7
|
L
H
8.9
32.7
|
| Wellgistics Health Inc |
|
40.9
|
0.4
|
L
 -2.4%
H
0.4
0.4
|
L
 -2.4%
H
0.4
0.4
|
L
 -7.0%
H
0.4
0.5
|
L
 -65.2%
H
0.4
0.9
|
L
H
0.3
7.0
|
L
H
0.3
7.0
|
L
H
0.3
7.0
|
L
H
0.3
7.0
|
| Kestra Medical Tech Ltd |
|
1,435.4
|
24.6
|
L
 -0.5%
H
24.0
25.0
|
L
 7.7%
H
22.1
25.0
|
L
 -10.6%
H
21.4
27.6
|
L
 -5.4%
H
21.4
30
|
L
H
13.3
30
|
L
H
13.3
30
|
L
H
13.3
30
|
L
H
13.3
30
|
| Sanuwave Health Inc |
|
228.0
|
26.6
|
L
 -2.8%
H
26.2
27.6
|
L
 -1.8%
H
26.2
28.6
|
L
 -13.3%
H
26.2
32.9
|
L
 -14.1%
H
25.8
36.2
|
L
 -17.7%
H
24.8
46.6
|
L
 -17.7%
H
24.8
46.6
|
L
 -17.7%
H
24.8
46.6
|
L
 -17.7%
H
24.8
46.6
|
| SS Innovations Intl Inc |
|
1,037.8
|
5.4
|
L
 -2.9%
H
5.3
5.7
|
L
 -9.6%
H
5.3
6.0
|
L
 -10.8%
H
5.1
6.1
|
L
 -40.2%
H
5.0
9.1
|
L
H
3.0
22.4
|
L
H
3.0
22.4
|
L
H
3.0
22.4
|
L
H
3.0
22.4
|
| Medline Inc Ordinary Shares |
|
38,281.4
|
46
|
L
 0.1%
H
44.9
46.6
|
L
 4.3%
H
42.2
46.6
|
L
 3.9%
H
38.5
46.6
|
L
 12.2%
H
38
46.6
|
L
 12.2%
H
38
46.6
|
L
 12.2%
H
38
46.6
|
L
 12.2%
H
38
46.6
|
L
 12.2%
H
38
46.6
|